Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

Clinical trial NCT03016715 · UNKNOWN

Trial details

NCT number: NCT03016715
Sponsor: Premier Specialists, Australia
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Simplex Epidermolysis Bullosa Simplex Kobner Weber-Cockayne Syndrome

Start date: 2016-05-01
Primary completion: 2019-06-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.